Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Kasper W. ter Horst, Mireille J. Serlie
Nutrients (2017) Vol. 9, Iss. 9, pp. 981-981
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra, Gianluca Svegliati‐Baroni
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 280-295
Closed Access | Times Cited: 690
Fructose metabolism and metabolic disease
Sarah Anissa Hannou, Danielle E. Haslam, Nicola M. McKeown, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 545-555
Open Access | Times Cited: 465
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Steven Zhao, Cholsoon Jang, Joyce Liu, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 586-591
Open Access | Times Cited: 422
Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity
Ann Hammarstedt, Silvia Gogg, Shahram Hedjazifar, et al.
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 1911-1941
Open Access | Times Cited: 361
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 349
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Gopanandan Parthasarathy, Xavier S. Revelo, Harmeet Malhi
Hepatology Communications (2020) Vol. 4, Iss. 4, pp. 478-492
Open Access | Times Cited: 347
Dietary Fructose and the Metabolic Syndrome
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 245
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Jinchunzi Yang, Marta Fernández‐Galilea, Leyre Martínez‐Fernández, et al.
Nutrients (2019) Vol. 11, Iss. 4, pp. 872-872
Open Access | Times Cited: 234
Fructose and hepatic insulin resistance
Samir Softic, Kimber L. Stanhope, Jérémie Boucher, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 5, pp. 308-322
Open Access | Times Cited: 196
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 195
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1069-1083
Open Access | Times Cited: 143
CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
Han Zeng, Hong Qin, Meng Liao, et al.
Molecular Metabolism (2021) Vol. 57, pp. 101428-101428
Open Access | Times Cited: 131
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 86
Tolerable upper intake level for dietary sugars
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 82
High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate
Peng Zhou, Wen-yi Chang, Deao Gong, et al.
Cell Metabolism (2023) Vol. 35, Iss. 11, pp. 1961-1975.e6
Open Access | Times Cited: 42
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 2
Dietary stearic acid regulates mitochondria in vivo in humans
Deniz Senyilmaz, Daniel Pfaff, Sam Virtue, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 110
Intestinal Fructose and Glucose Metabolism in Health and Disease
Beatriz Merino, Cristina M. Fernández-Díaz, Irene Cózar‐Castellano, et al.
Nutrients (2019) Vol. 12, Iss. 1, pp. 94-94
Open Access | Times Cited: 94
The sensory properties and metabolic impact of natural and synthetic sweeteners
Margaux R. Mora, Robin Dando
Comprehensive Reviews in Food Science and Food Safety (2021) Vol. 20, Iss. 2, pp. 1554-1583
Closed Access | Times Cited: 93
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Raúl D. Santos, Luca Valenti, Stefano Romeo
Atherosclerosis (2019) Vol. 282, pp. 110-120
Closed Access | Times Cited: 87
Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View
Rodrigo Valenzuela, Luis A. Videla
Nutrients (2020) Vol. 12, Iss. 2, pp. 499-499
Open Access | Times Cited: 84
Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
Sara Della Torre
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 80
Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease
Pankaj Prasun, Ilona Ginevic, Kimihiko Oishi
Translational Gastroenterology and Hepatology (2020) Vol. 6, pp. 4-4
Open Access | Times Cited: 77
High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats
Yong Wang, Wentao Qi, Ge Song, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 72
Fructose Metabolism in Cancer
Nils Krause, André Wegner
Cells (2020) Vol. 9, Iss. 12, pp. 2635-2635
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top